Modern hybrid imaging for staging and monitoring patients with oral squamous cell carcinoma - effects on staging and therapy

Modern hybrid imaging for staging and monitoring patients with oral squamous cell carcinoma - effects on staging and therapy - PETOSCC

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00020923

Enrollment

300

Registered

2020-05-07

Start date

2013-06-19

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C01 C14

Interventions

Group 1: Patients with head and neck malignancy in preoperative staging As part of preoperative tumostaging, an FDG-PET/CT (includinfg a diagnostic contrast-enhanced CT) and an MRI are performed. Den

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Malignancy of the head and neck, complete imaging (FDG / PET-CT, CT and MRI)

Exclusion criteria

Exclusion criteria: Not eligible for consent, under 18 years old, pregnant

Design outcomes

Primary

Measure	Time frame
Comparison of sensitivity and specificity in preoperative tumor staging	—

Secondary

Measure	Time frame
Advantages in the treatment concept in the course of improved imaging (as part of the clinical rountine)	—

Countries

Germany

Contacts

Public ContactChristian Linz

Klinik für Mund-, Kiefer- und Plastische Gesichtschirurgie

mkg@ukw.de004993120172720

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026